| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/12/2012 | CN102821787A Antibody formulation and therapeutic regimens |
| 12/12/2012 | CN102821786A Injectable solution containing therapeutic agent for osteoarthritis |
| 12/12/2012 | CN102821785A Process for producing an allergen extract |
| 12/12/2012 | CN102816779A Novel tuberculosis vaccine and combined vaccine thereof |
| 12/12/2012 | CN102816771A Preparation and application of green hata Beta lymphocyte stimulator gene and protein |
| 12/12/2012 | CN102816743A Human ubiquitin ligase E3 for the modulation of NF-Kappa B |
| 12/12/2012 | CN102816741A Preparation method and application of newcastle disease virus living-vector vaccine through gene recombination of canine distemper attenuated vaccine strains F and H |
| 12/12/2012 | CN102816740A Avian influenza virus, inactivated vaccine and method for preparing same |
| 12/12/2012 | CN102816732A MDCK cell line suitable for full suspended serum-free culture and its application in culturing of influenza virus and production of influenza virus vaccines |
| 12/12/2012 | CN102816246A Human cytomegalo virus immunogen fusion protein as well as preparation method and usage thereof |
| 12/12/2012 | CN102816239A Specific composite IgY (immunoglobulin of yolk) for resisting human telomerase reverse transcriptase (hTERT) and human epidermal growth factor receptor-2 (HER2) and preparation method of specific composite IgY |
| 12/12/2012 | CN102816222A Chicken E.tenella MA2 gene, vector, recombinant strain, protein, and application thereof |
| 12/12/2012 | CN102816221A Chicken E. tenella MA1 (EtMA1) gene, vector, recombinant strain, EtMA1 protein, EtMA1-Outside domain, and use of the EtMA1 protein and the EtMA1-Outside domain |
| 12/12/2012 | CN102816218A Mycobacterium tuberculosis dormant antigen phoY2 protein, and preparation method and application thereof |
| 12/12/2012 | CN102816216A Polypeptide capable of inducing granulation and application thereof |
| 12/12/2012 | CN102816189A Alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for immune adjuvant containing the same as active ingredient |
| 12/12/2012 | CN102813933A Chicken infectious bursal disease egg yolk antibody cryoprotectant |
| 12/12/2012 | CN102813932A Duck viral hepatitis egg yolk antibody cryoprotectant |
| 12/12/2012 | CN102813923A Combination Therapy for the Treatment of Ocular Neovascular Disorders |
| 12/12/2012 | CN102813922A Compound oil adjuvant as well as preparation method and application thereof |
| 12/12/2012 | CN102813921A Novel compound aluminum hydroxide adjuvant for foot-and-mouth disease vaccine and vaccine preparation method |
| 12/12/2012 | CN102813920A Vaccine adjuvant |
| 12/12/2012 | CN102813919A Recombinant canine distemper vaccine for expressing hemagglutinin repeatedly and preparation method |
| 12/12/2012 | CN102813918A Porcine circovirus 2 type recombinant subunit vaccine and preparation method thereof |
| 12/12/2012 | CN102813917A Diphtheria, tetanus and acellular pertussis/Haemophilus influenzae type b - group A and C meningococcus combined vaccine |
| 12/12/2012 | CN102813916A Method for quickly preparing dentritic cell vaccine and application of dentritic cell vaccine |
| 12/12/2012 | CN102813915A Drug-induced subcellular structure vaccine and preparation method thereof |
| 12/12/2012 | CN102228482B Propolis injection for preventing duck hemorrhagic oophoritis and preparation method thereof |
| 12/12/2012 | CN102000328B Method for manufacturing Marek's disease vaccine by utilizing cell factory |
| 12/12/2012 | CN101974489B A H1N1 influenza virus and application thereof |
| 12/12/2012 | CN101920012B Method for producing porcine circovirus type II recombinant capsid protein subunit vaccine by utilizing silkworm bioreactor and products thereof |
| 12/12/2012 | CN101837117B Application of B cell epitope peptide from tetanus exotoxin fragment C |
| 12/12/2012 | CN101829321B Vaccine for preventing red head disease of Pseudobagrus fulvidraco |
| 12/12/2012 | CN101791400B Fish soaking vaccine specific immunity intensifier and application and using method thereof |
| 12/12/2012 | CN101732710B Foot and mouth disease virus inhibitor and preparation method and application thereof |
| 12/12/2012 | CN101633695B Preparation method of anti-erbB2 functional antibody based on erbB2 protein extracellular C-terminal functional epitope characteristics |
| 12/12/2012 | CN101511869B Anti-MCP-1 antibodies, compositions, methods and uses |
| 12/12/2012 | CN101506236B Monoclonal antibodies against amyloid beta protein and uses thereof |
| 12/12/2012 | CN101400366B Hepatitis c virus non structural fusion protein |
| 12/11/2012 | US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use |
| 12/11/2012 | US8329886 Nucleic acid molecules encoding anti-amyloid beta antibodies |
| 12/11/2012 | US8329881 Metastatic colorectal cancer vaccine |
| 12/11/2012 | US8329865 Antimicrobially active peptides |
| 12/11/2012 | US8329660 Tim-3 (t cell immunoglobulin and mucin domain containing molecule) polypeptide for use in enhancement of immune and transplantaion tolerance |
| 12/11/2012 | US8329654 Use of IL-6/IL-6 chimera in Huntington's disease |
| 12/11/2012 | US8329635 Method for the preparation of specific antibodies against saccharidic antigens |
| 12/11/2012 | US8329466 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 12/11/2012 | US8329396 Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) |
| 12/11/2012 | US8329209 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 12/11/2012 | US8329197 Ex vivo uses of immunostimulatory combinations |
| 12/11/2012 | US8329196 Allergen dosage form |
| 12/11/2012 | US8329195 Detoxified pneumococcal neuraminidase and uses thereof |
| 12/11/2012 | US8329194 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| 12/11/2012 | US8329193 Method for treating premature ejaculation with a botulinum neurotoxin |
| 12/11/2012 | US8329192 Campylobacter polypeptides and methods of use |
| 12/11/2012 | US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 12/11/2012 | US8329189 Immunoreactive Ehrlichia p120/p140 epitopes and uses thereof |
| 12/11/2012 | US8329188 Human M2e peptide immunogens |
| 12/11/2012 | US8329187 Compositions of spores of non pathogenic bacteria |
| 12/11/2012 | US8329186 Treatment of inflammation using BST2 inhibitor |
| 12/11/2012 | US8329185 Method for isolating and purifying grass pollen allergens |
| 12/11/2012 | US8329184 Process for manufacturing vaccines |
| 12/11/2012 | US8329183 Recombinant fusion protein and polynucleotide construct for immunotoxin production |
| 12/11/2012 | US8329182 Immunoglobulin chimeric monomer-dimer hybrids |
| 12/11/2012 | US8329181 Methods for treating B-cell lymphoma by administering an anti-CD20 antibody |
| 12/11/2012 | US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/11/2012 | US8329179 Death domain containing receptor 4 antibodies and methods |
| 12/11/2012 | US8329178 Antibodies against CXCR4 and methods of use thereof |
| 12/11/2012 | US8329177 Method of treating hypertrophic cardiomyopathy |
| 12/11/2012 | US8329176 Method for inhibiting bone resorption |
| 12/11/2012 | US8329175 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| 12/11/2012 | US8329173 Antibodies inhibiting c-Met dimerization and uses thereof |
| 12/11/2012 | US8329172 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 12/11/2012 | US8329171 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody |
| 12/11/2012 | US8329170 Method for treating psoriasis by administering an anti-IL-12 antibody |
| 12/11/2012 | US8329169 Methods and compositions for the prevention and treatment of sepsis |
| 12/11/2012 | US8329164 Methods and compositions concerning poxviruses and cancer |
| 12/11/2012 | US8329163 Attenuated gram negative bacteria |
| 12/11/2012 | US8329144 Diagnostic and therapeutic epitope, and transgenic plant |
| 12/11/2012 | CA2661042C Agents for blood-brain barrier delivery |
| 12/11/2012 | CA2650202C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 12/11/2012 | CA2639048C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 12/11/2012 | CA2606348C Anti-il-6 antibodies, compositions, methods and uses |
| 12/11/2012 | CA2549467C A preventive agent for vasculitis |
| 12/11/2012 | CA2540848C Method for stabilizing antibody and stabilized solution-type antibody preparation |
| 12/11/2012 | CA2524534C Methods and compositions for the prevention and treatment of sepsis |
| 12/11/2012 | CA2513104C Survivin-derived peptides and use thereof |
| 12/11/2012 | CA2503871C An immunogenic composition for generating an immune response against polio virus |
| 12/11/2012 | CA2494008C Anti-myelin associated glycoprotein (mag) antibodies |
| 12/11/2012 | CA2481479C Novel flavivirus antigens |
| 12/11/2012 | CA2388054C Compositions and methods for stimulating an immune response against infectious agents |
| 12/11/2012 | CA2202519C Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase |
| 12/06/2012 | WO2012167230A1 In situ antigen-generating cancer vaccine |
| 12/06/2012 | WO2012167144A1 Nanocoatings for biological materials |
| 12/06/2012 | WO2012167039A1 Fc RECEPTOR BINDING PROTEINS |
| 12/06/2012 | WO2012167032A1 Compositions and methods for treating pain |
| 12/06/2012 | WO2012167028A2 Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition |
| 12/06/2012 | WO2012166991A1 S-nitrosylation of glucosylating toxins and uses therefor |
| 12/06/2012 | WO2012166859A2 Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand rna virus infections |
| 12/06/2012 | WO2012166743A2 Fusion proteins of ciliate granule lattice proteins, granular protein particles thereof, and uses therefor |